Biopolis has capabilities from sourcing and screening of novel strains, to preclinical and clinical evaluation, scale-up and industrial manufacturing of probiotics. The Company has developed both proprietary and tailored strains for its partners infant nutrition and produces several tons of probiotics every year.


Activities in this Unit are based in the use of the Caenorhabditis elegans preclinical model for the evaluation of novel food and pharmaceutical active ingredients.  Biopolis has developed proprietary functional ingredients and probiotics and has helped its partners in the development of their own products.


We offer R&D services to the Chemical and Pharmaceutical industries. We are specialized in microbial strain and bioprocess design and development, including fermentation and downstream set-up and optimization, for the overproduction of valuable metabolites, such as proteins, specialized sugars and biopolymers.

We use cookies to ensure that we give you the best experience on our website. If you continue browsing, you are giving your consent for the acceptance of the cookies and our cookie policy , click on the link for more information.

Aviso de cookies